Janice Lu, MD, PhD headshot

Janice Lu, MD, PhD

Director of Breast Medical OncologyNorthwestern University Feinberg School of Medicine

Janice Lu, MD, PhD, is director of breast medical oncology and clinical co-leader of the Breast Cancer Research Program at Northwestern University Feinberg School of Medicine.

Disclosures: Dr. Lu reported financial relationships with AstraZeneca, Ambrx, Daiichi Sankyo, Eli Lilly, Pfizer, Radius Health, Sanofi, and SeaGen.

Related

Janice Lu, MD, PhD
Breast Cancer

Maximizing Outcomes in HR+/HER2- Breast Cancer

Janice Lu, MD, PhD
Video

Janice Lu, MD, PhD, discusses three abstracts that can help guide treatment choices for HR+/HER2- breast cancer with mutations in ESR1, PIK3CA, PTEN, or AKT.

Janice Lu, MD, PhD
Breast Cancer

Maximizing Outcomes in HR+/HER2- Breast Cancer

Janice Lu, MD, PhD
Video

Janice Lu, MD, PhD, discusses three abstracts that can help guide treatment choices for HR+/HER2- breast cancer with mutations in ESR1, PIK3CA, PTEN, or AKT.